HGH dose guide

HGH dosage

Recombinant human growth hormone — an identical copy of the GH your pituitary makes. It stimulates IGF-1 production, fat burning, muscle protein synthesis and tissue repair. FDA-approved since the 1980s for GH deficiency and several growth disorders, but not for aging or athletic use: in healthy adults, trials show about 2 kg of fat swapped for lean mass, with no strength gain and more side effects. Commonly reported: water retention, numb or tingling fingers, joint aches, and better sleep and skin. Requires careful dosing and IGF-1 monitoring — more is not always better.

Dose range

1–4 IU (research range). Studied in research — not a recommendation.

How often

Daily: Daily SubQ injection.

A typical run

Commonly reported starting dose 1-2 IU daily. Advanced users may run 3-4 IU split AM/PM. Cycles of 3-6+ months common. Monitor IGF-1 levels. Also run alongside peptide stacks; some advanced protocols add insulin, which isn't in this library.

How it’s taken

Vial: SubQ injection

Evidence

Established: Clinical trials or FDA-approved use exists

Half-life

~3-4 hours (SubQ)

HGH on your syringe

Dosed in IU: the units on the syringe come from the IU on its vial.

HGH in the peptide libraryThe Dose Guide: every peptide

More growth hormone peptides

• Ipamorelin 200–300 mcg
• CJC-1295 with DAC 1–2 mg
• CJC-1295 no DAC 100–200 mcg
• Sermorelin 200–500 mcg
• Tesamorelin 1–2 mg
• GHRP-2 100–300 mcg
• GHRP-6 100–300 mcg
• Hexarelin 100–200 mcg
• MK-677 10–25 mg
• Fragment 176-191 250–500 mcg
• IGF-1 LR3 20–50 mcg
• PEG-MGF 200–400 mcg
• Follistatin-344 100–200 mcg

A community reference, not medical advice. Each range is what has been studied or is commonly run, never a dose for you.